Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics Stock Forecast

Stock Price Forecast

The 11 analysts that cover Relay Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $18.4, which forecasts a 411.11% increase in the stock price over the next year. The lowest target is $10 and the highest is $24.

Price Target: $18.4 (+411.11%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$10	$18.4	$18	$24
Change	+177.78%	+411.11%	+400.00%	+566.67%

* Price targets were last updated on May 7, 2025.

Analyst Ratings

The average analyst rating for Relay Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	5	5	5	6	6	6
Buy	4	4	4	4	4	4
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Schmidt Guggenheim	Guggenheim	Strong Buy Maintains $30 → $10	Strong Buy	Maintains	$30 → $10	+177.78%	May 7, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $16	Strong Buy	Reiterates	$16	+344.44%	Mar 7, 2025
Salveen Richter Goldman Sachs	Goldman Sachs	Strong Buy Maintains $20 → $18	Strong Buy	Maintains	$20 → $18	+400.00%	Feb 27, 2025
Bradley Canino Stifel	Stifel	Strong Buy Maintains $27 → $23	Strong Buy	Maintains	$27 → $23	+538.89%	Feb 27, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $16	Strong Buy	Reiterates	$16	+344.44%	Jan 14, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

11.77M

Increased by 17.59%

from 10.01M

Revenue Next Year

11.74M

Decreased by -0.22%

from 11.77M

EPS This Year

-1.91

from -2.36

EPS Next Year

-1.86

from -1.91

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	82.65M	3.03M	1.38M	25.55M	10.01M	11.77M	11.74M	22.40M
Revenue Growth	-	-96.34%	-54.41%	1,749.82%	-60.83%	17.59%	-0.22%	90.74%
EPS	-5.40	-3.82	-2.59	-2.79	-2.36	-1.91	-1.86	-1.91
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	14	13	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	39.6M	47.3M	112.7M
Avg	11.8M	11.7M	22.4M
Low	7.5M	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	295.6%	301.5%	859.8%
Avg	17.6%	-0.2%	90.7%
Low	-24.8%	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-1.29	-1.30	-1.41
Avg	-1.91	-1.86	-1.91
Low	-2.17	-2.31	-2.40

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.